Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples

PUBLISHER: 360iResearch | PRODUCT CODE: 1614197

Cover Image

PUBLISHER: 360iResearch | PRODUCT CODE: 1614197

Endotoxin Testing Market by Offering (Instruments, Reagents & Kits, Software), Test Type (Chromogenic Tests, Gel Clot Tests, Limulus Amebocyte Lysate Test), Application, End-Use - Global Forecast 2025-2030

PUBLISHED:
PAGES: 186 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF, Excel & 1 Year Online Access (Single User License)
USD 3939
PDF, Excel & 1 Year Online Access (2-5 User License)
USD 4249
PDF, Excel & 1 Year Online Access (Site License)
USD 5759
PDF, Excel & 1 Year Online Access (Enterprise User License)
USD 6969

Add to Cart

Description

Table of Contents

List of Tables

The Endotoxin Testing Market was valued at USD 1.22 billion in 2023, expected to reach USD 1.33 billion in 2024, and is projected to grow at a CAGR of 9.47%, to USD 2.30 billion by 2030.

Endotoxin testing serves a critical role in ensuring the safety and efficacy of pharmaceuticals, biologics, and medical devices by detecting bacterial toxins that could trigger adverse reactions in humans. The necessity of endotoxin testing arises from stringent regulatory requirements aimed at preventing contamination in injectable drugs and implants, which could result in severe complications or even fatalities. Applications are broad, spanning pharmaceutical manufacturing, medical device production, and biologics, with end-use sectors including hospitals, research laboratories, biotechnology firms, and regulatory bodies. The market for endotoxin testing is primarily driven by the escalating demand for biologics and biosimilars, heightened focus on quality control in pharmaceutical operations, and rising health awareness that increases regulatory scrutiny. Technological advancements like the recombinant Factor C (rFC) assay, which offers sustainable testing methods avoiding animal testing, present significant opportunities. Increasing R&D investments in the biopharmaceutical sector can further bolster market growth. However, challenges such as the high cost of testing instruments, complex regulatory frameworks, and the need for skilled personnel could impede market expansion. Furthermore, the COVID-19 pandemic has reshaped market dynamics, illuminating gaps in the supply chain that companies should address to enhance resilience. The newest potential opportunities lie in the digital transformation of laboratory processes, integration of artificial intelligence for predictive analytics in testing, and enhancing the adoption of cost-effective, rapid testing kits. Companies can innovate by developing automated endotoxin testing systems and exploring partnerships with biotech and pharma firms for tailored solutions. While market growth appears robust, stakeholders should prioritize regulatory compliance and technological innovation to overcome existing bottlenecks. Overall, as the demand for high-quality, contamination-free pharmaceutical and biotechnology products increases, the endotoxin testing market holds promising potential for expansion and innovation.

KEY MARKET STATISTICS
Base Year [2023] USD 1.22 billion
Estimated Year [2024] USD 1.33 billion
Forecast Year [2030] USD 2.30 billion
CAGR (%) 9.47%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Endotoxin Testing Market

The Endotoxin Testing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising prevalence of chronic illnesses across the globe
    • Surge in biologics and generics production due to their cost-effectiveness
    • Integration of endotoxin testing across different stages of drug development
  • Market Restraints
    • High costs associated with endotoxin testing procedures
  • Market Opportunities
    • Advancements in Limulus Amebocyte Lysate technology
    • Government mandates for use of endotoxin testing across stages of pharmaceutical production
  • Market Challenges
    • Variability in test results of endotoxin testing solutions

Porter's Five Forces: A Strategic Tool for Navigating the Endotoxin Testing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Endotoxin Testing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Endotoxin Testing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Endotoxin Testing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Endotoxin Testing Market

A detailed market share analysis in the Endotoxin Testing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Endotoxin Testing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Endotoxin Testing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Endotoxin Testing Market

A strategic analysis of the Endotoxin Testing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Endotoxin Testing Market, highlighting leading vendors and their innovative profiles. These include Accugen Laboratories, Inc., Agilent Technologies, Inc., ARL Bio Pharma, Associates of Cape Cod, Inc., Bio-Rad Laboratories, Inc., Bio-Synthesis Inc., BioMerieux SA, Charles River Laboratories International, Inc., Eurofins Scientific SE, Fujifilm Corporation, GenScript Biotech Corporation, Labcorp, Lonza Group Ltd., Merck KGaA, METTLER TOLEDO, Nelson Laboratories, LLC by Sotera Health Company, Pace Analytical Services, LLC, Pacific BioLabs, QIAGEN N.V., SGS SA, Thermo Fisher Scientific Inc., Waters Corporation, and WuXi AppTec Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Endotoxin Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Offering, market is studied across Instruments, Reagents & Kits, and Software.
  • Based on Test Type, market is studied across Chromogenic Tests, Gel Clot Tests, Limulus Amebocyte Lysate Test, and Turbidimetric Tests.
  • Based on Application, market is studied across Clinical Testing, Medical Device Testing, and Pharmaceutical & Biotechnology Testing.
  • Based on End-Use, market is studied across Contract Research Organizations, Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, and Research & Academic Institutes.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Show more
Product Code: MRR-CB04E05657E7

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of chronic illnesses across the globe
      • 5.1.1.2. Surge in biologics and generics production due to their cost-effectiveness
      • 5.1.1.3. Integration of endotoxin testing across different stages of drug development
    • 5.1.2. Restraints
      • 5.1.2.1. High costs associated with endotoxin testing procedures
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements in Limulus Amebocyte Lysate technology
      • 5.1.3.2. Government mandates for use of endotoxin testing across stages of pharmaceutical production
    • 5.1.4. Challenges
      • 5.1.4.1. Variability in test results of endotoxin testing solutions
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Offering: Utilization of LAL test cartridges and systems in endotoxin testing to ensure the accuracy and regulatory compliance
    • 5.2.2. Application: Increasing usage of endotoxin testing to ensure the safety and efficacy of medical and pharmaceutical products in clinical settings
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Endotoxin Testing Market, by Offering

  • 6.1. Introduction
  • 6.2. Instruments
  • 6.3. Reagents & Kits
  • 6.4. Software

7. Endotoxin Testing Market, by Test Type

  • 7.1. Introduction
  • 7.2. Chromogenic Tests
  • 7.3. Gel Clot Tests
  • 7.4. Limulus Amebocyte Lysate Test
  • 7.5. Turbidimetric Tests

8. Endotoxin Testing Market, by Application

  • 8.1. Introduction
  • 8.2. Clinical Testing
  • 8.3. Medical Device Testing
  • 8.4. Pharmaceutical & Biotechnology Testing

9. Endotoxin Testing Market, by End-Use

  • 9.1. Introduction
  • 9.2. Contract Research Organizations
  • 9.3. Hospitals & Diagnostic Centers
  • 9.4. Pharmaceutical & Biotechnology Companies
  • 9.5. Research & Academic Institutes

10. Americas Endotoxin Testing Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Endotoxin Testing Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Endotoxin Testing Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Enhanced Precision in Biopharmaceutical Endotoxin Testing Through Strategic Collaboration
    • 13.3.2. Charles River Launches Innovative Animal-Free Rapid Endotoxin Testing Solution
    • 13.3.3. Lonza Introduces the Nebula Absorbance Reader for Enhanced Endotoxin Detection
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Accugen Laboratories, Inc.
  • 2. Agilent Technologies, Inc.
  • 3. ARL Bio Pharma
  • 4. Associates of Cape Cod, Inc.
  • 5. Bio-Rad Laboratories, Inc.
  • 6. Bio-Synthesis Inc.
  • 7. BioMerieux SA
  • 8. Charles River Laboratories International, Inc.
  • 9. Eurofins Scientific SE
  • 10. Fujifilm Corporation
  • 11. GenScript Biotech Corporation
  • 12. Labcorp
  • 13. Lonza Group Ltd.
  • 14. Merck KGaA
  • 15. METTLER TOLEDO
  • 16. Nelson Laboratories, LLC by Sotera Health Company
  • 17. Pace Analytical Services, LLC
  • 18. Pacific BioLabs
  • 19. QIAGEN N.V.
  • 20. SGS SA
  • 21. Thermo Fisher Scientific Inc.
  • 22. Waters Corporation
  • 23. WuXi AppTec Co., Ltd.
Show more
Product Code: MRR-CB04E05657E7

LIST OF FIGURES

  • FIGURE 1. ENDOTOXIN TESTING MARKET RESEARCH PROCESS
  • FIGURE 2. ENDOTOXIN TESTING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ENDOTOXIN TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ENDOTOXIN TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ENDOTOXIN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS ENDOTOXIN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS ENDOTOXIN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES ENDOTOXIN TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES ENDOTOXIN TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC ENDOTOXIN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC ENDOTOXIN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ENDOTOXIN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ENDOTOXIN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. ENDOTOXIN TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. ENDOTOXIN TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ENDOTOXIN TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ENDOTOXIN TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ENDOTOXIN TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ENDOTOXIN TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ENDOTOXIN TESTING MARKET DYNAMICS
  • TABLE 7. GLOBAL ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ENDOTOXIN TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ENDOTOXIN TESTING MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ENDOTOXIN TESTING MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ENDOTOXIN TESTING MARKET SIZE, BY CHROMOGENIC TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ENDOTOXIN TESTING MARKET SIZE, BY GEL CLOT TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ENDOTOXIN TESTING MARKET SIZE, BY LIMULUS AMEBOCYTE LYSATE TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ENDOTOXIN TESTING MARKET SIZE, BY TURBIDIMETRIC TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL ENDOTOXIN TESTING MARKET SIZE, BY CLINICAL TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL ENDOTOXIN TESTING MARKET SIZE, BY MEDICAL DEVICE TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL ENDOTOXIN TESTING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL ENDOTOXIN TESTING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL ENDOTOXIN TESTING MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL ENDOTOXIN TESTING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL ENDOTOXIN TESTING MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS ENDOTOXIN TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. MEXICO ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES ENDOTOXIN TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC ENDOTOXIN TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. AUSTRALIA ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. AUSTRALIA ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. CHINA ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. CHINA ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. INDIA ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. INDIA ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. INDONESIA ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. INDONESIA ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. JAPAN ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. JAPAN ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. MALAYSIA ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. MALAYSIA ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. PHILIPPINES ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. PHILIPPINES ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. SINGAPORE ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. SINGAPORE ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH KOREA ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. SOUTH KOREA ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. TAIWAN ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. TAIWAN ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. THAILAND ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. THAILAND ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. VIETNAM ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. VIETNAM ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA ENDOTOXIN TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. DENMARK ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. DENMARK ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. EGYPT ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. EGYPT ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. FINLAND ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. FINLAND ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. FRANCE ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. FRANCE ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. GERMANY ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. GERMANY ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. ISRAEL ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. ISRAEL ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. ITALY ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. ITALY ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. NETHERLANDS ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. NETHERLANDS ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. NIGERIA ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. NIGERIA ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. NORWAY ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 148. NORWAY ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. POLAND ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 152. POLAND ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. QATAR ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 156. QATAR ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. RUSSIA ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 160. RUSSIA ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. SAUDI ARABIA ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 164. SAUDI ARABIA ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH AFRICA ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 168. SOUTH AFRICA ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. SPAIN ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 172. SPAIN ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. SWEDEN ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 176. SWEDEN ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. SWITZERLAND ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 180. SWITZERLAND ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. TURKEY ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 184. TURKEY ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED ARAB EMIRATES ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED ARAB EMIRATES ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED KINGDOM ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 192. UNITED KINGDOM ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 193. ENDOTOXIN TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 194. ENDOTOXIN TESTING MARKET, FPNV POSITIONING MATRIX, 2023
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!